Retrospective Outcome Data for Hematopoietic Stem Cell Transplantation in Patients with Concurrent Coronary Artery Disease

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 8, 2011, Pages 1182-1186

  Stillwell, Elizabeth E ^a   Wessler, Jeffrey D ^b   Rebolledo, Brian J ^c   Steingart, Richard M ^a   Petrlik, Erica L ^a   Jakubowski, Ann A ^a   Schaffer, Wendy L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Coronary artery disease; Hematopoietic stem cell transplantation

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BYPASS SURGERY; CANCER DIAGNOSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960243435     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.12.698     Document Type: Article

References (5)

1. Mileshkin L.R., Seymour J.F., Wolf M.M., et al. Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older. Leuk Lymphoma 2005, 46:1575-1579.
2. Sirohi B., Powles R., Treleaven J., et al. The role of autologous transplantation in patients with multiple myeloma aged 65 years and older. Bone Marrow Transplant 2000, 25:5333-5539.
3. Jakubowski A.A., Small T.N., Kernan N.A., et al. T cell-depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 2007, 110:4552-4559.
4. Muzaffar H.Q., Amjad A.I., Qureshi S., et al. Outcome of allogeneic hematopoietic stem cell transplantation in patient with low left ventricular ejection fraction. Biol Blood Marrow Transplant 2009, 15:1265-1270.
5. Tang W.H.W., Thomas S., Kalaycio M., et al. Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?. Bone Marrow Transplant 2004, 34:603-607.